Wolters Kluwer Pharma SolutionsinThought
 Home About Us The Data The Analysis Contact Us
Government Affairs Brief


 Julie HoggattThe Team



JULIE HOGGATT
Senior Analyst 

Ms. Hoggatt covers the medical technology industry. Ms. Hoggatt comes from Noble
Financial where she was the Senior Medical Technology analyst. 

Prior to Noble, Ms. Hoggatt helped start the independent research firm, Variant Research with Dr. Weintraub and Dr. Henderson.   Before Variant she worked at Hibernia Southcoast Capital, where she was also a Medical Technology Analyst and a Vice President of Equity Research.  Ms. Hoggatt began in the investment industry as an associate equity analyst at Morgan Keegan & Company covering medical devices and earned the title Associate Vice President of Equity Research.  Her professional career has been focused on the healthcare sector and has included in-depth coverage of over thirty different companies in the Medical Technology and Medical Device industries, allowing her to share a wealth of knowledge and insight with our clients. Ms. Hoggatt received her Bachelors of Business Administration and Master of Accountancy from Millsaps College in Jackson, Mississippi.

 Marc Engelsgjerd, M.D. - Senior Principal
 Leon Henderson, M.D. - Medical Consultant
 Julie Hoggatt - Senior Analyst 
 Ben Weintraub, Ph.D. - Director of Research
 Claudia Wiatr - Senior Analyst  
 David Yee, Ph.D. - Research Analyst
 Michael Zuckerman, M.D. - Director of Medical Affairs


 

Contents
  Marc Engelsgjerd, M.D.
  Leon Henderson, M.D.
  Julie Hoggatt
  Ben Weintraub, Ph.D.
  Claudia Wiatr
  David Yee, Ph.D.
  Michael Zuckerman, M.D.

Contents
 Research Example PDFs:
  Contrave Post Panel (Dec-10)
  Gilenya Survey (Nov-10)
  New Inhibitors target (Nov-10)
  Hepatitis C Survey (Oct-10)
  ASHG Preview (Oct-10)





 

 

Home | About Us | The Data | The Analysis | Contact Us | visit Wolters Kluwer Pharma Solutions © 2011 Wolters Kluwer Pharma Solutions